Conclusions
Monoclonal antibodies have been obtained that are specific for cell surface antigens of human tumors. Some of these antigens are tissue type specific tumor antigens, most strongly expressed on tumors of the same histological type. The antigens identified by the monoclonal antibodies are primarily normal differentiation antigens that are expressed more strongly on neoplastic cells than on most normal adult cells. For several antigens, the higher degree of antigen expression on neoplastic cells appear to be adequate for diagnostic and therapeutic purposes. Future work in this area is likely to have far-reaching consequences for the clinical handling of human cancer patients.
Similar content being viewed by others
References
Accola R S, Buchegger F, Carrel S, Mach J-P (1981) Monoclonal antibodies against carcinoembryonic antigens and their possible applications. In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol. 3. North-Holland Biomedical Press, Amsterdam, p209
Aisenberg AC, Wilkes B M (1981) Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia. Cancer Res 41: 4810
Atassi M Z (1978) Precise determination of the entire antigenic structure of lysozyme: molecular features of protein antigenic structures and potential of surface stimulation synthesis — a powerful new concept for protein binding sites. Immunochemistry 15: 909
Ballou B, Levine G, Hakala TR, Solter D (1979) Tumor location detected with radioactively monoclonal antibody and external scintigraphy. Science 206: 844
Bast R C Jr, Zbar B, Borsos T, Rapp H J (1974) BCG and cancer. N Engl J Med 290: 1413
Bast R C Jr, Feeney M, Lazarus H, Nadler L M, Colvin R B, Knapp R C (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331
Bernstein I D, Tam M R, Nowinski R C (1980) Mouse leukemia therapy with monoclonal antibodies against a thymus differentiation antigen. Science 207: 68
Bluestone J A, Sharrow S O, Epstein S L, Ozato K, Sachs D H (1981) Induction of anti-H-2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype. Nature 291: 233
Blythman H E, Casellas P, Gros O, Gros P, Jansen F K, Paolucci F, Pau B, Vidal H (1981) Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kills tumour cells. Nature 290: 145
Bowman W P, Melvin S L, Aur R J A, Mauer A M (1981) A clinical perspective on cell markers in acute lymphocytic leukemia. Cancer Res 41: 4794
Brown J P, Hellström K E, Hellström I (to be published) Indirect 125I-labeled protein A assay for monoclonal antibodies to cell surface antigens. Methods Enzymol
Brown J P, Hellström K E, Hellström I (1981) Use of monoclonal antibodies for quantitative analysis of antigens in normal and neoplastic tissues. Clin Chem 27: 1592
Brown J P, Hewick R M, Hellström I, Hellström K E, Doolittle R F, Dreyer W J (1982) Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature 296: 171
Brown J P, Nishiyama K, Hellström I, Hellström K E (1981) Structural characterization of human melanoma-associated antigen p97 using monoclonal antibodies. J Immunol 127: 539
Brown J P, Woodbury R G, Hart C E, Hellström I, Hellström K E (1981) Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci USA 78: 539
Brown J P, Wright P W, Hart C E, Woodbury R G, Hellström K E, Hellström I (1980) Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies. J Biol Chem 255: 4980
Bubenik J, Perlmann P, Helmstein K, Moberger G (1970) Cellular and humoral immune response to human urinary bladder carcinomas. Int J Cancer 5: 310
Burtin P, Sabine M C, Chavanel G (1977) A comparative study of the localization of CEA and NCA2 in cancerous and normal gastointestinal tissues. Int J Cancer 19: 634
Byrd R L, Jonak Z L, Kennett K H (1982) Monoclonal antibodies against human neuroblastomas and leukemias: detection of metastasis and of molecules involved in growth regulation. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 219
Carrel S, Accolla R S, Carmagnola A L, Mach J-P (1980) Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res 40: 2523
Carrel S, Accolla R S, Gross N, Mach J-P (1981) Human melanoma-associated antigens identified by monoclonal antibodies. In: Hämmerling GJ, Hämmerling U, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Elsevier/North-Holland Biomedical Press, Amsterdam, p 174
Cassellas P, Brown J P, Gros O, Gros P, Hellström I, Jansen F K, Poncelet P, Roncucci R, Vidal H, Hellström K E (to be published) Immunotoxin potentiated by ammonium chloride specifically and efficiently kills human melanoma cells.
Colcher D, Horan Hand P, Nuti M, Schlom J (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 78: 3199
Cornain S, de Vries J E, Collard J, Vennegoor C, Wingerden I V, Rumke P (1975) Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer 19: 981
Cuttitta F, Rosen S, Gazdar A F, Minna J D (1981) Monoclonal antibodies that demonstrate specificity for several types of human lung cancer. Proc Natl Acad Sci USA 78: 4591
Dantas M E, Brown J P, Thomas M R, Robinson W A, Glode L M (to be published) Detection of melanoma cells in bone marrow using monoclonal antibodies: a comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF). Cancer
Dillman R O, Sobol R E, Collins H, Beauregard J, Royston I (1982) T101 monoclonal antibody therapy in chronic lymphocytic leukemia. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 151
Dippold W G, Lloyd K O, Li L T C, Ikeda H, Oettgen H F, Old L J (1980) Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 77: 6114
Doolittle R F (1981) Similar amino acid sequences: chance or common ancestry? Science 214: 149
Eisen H N, Sakato N, Hall S J (1975) Myeloma proteins as tumor-specific antigens. In: Murphy G P (ed) Cancer and transplantation. Grune and Stratton, New York, p 71
Embleton M J, Gunn B, Byers V S, Baldwin R W (1981) Anti-tumor reactions of monoclonal antibody against a human osteogenic sarcoma cell line. Br J Cancer 43: 582
Galloway D R, McDabe R P, Pellegrino M A, Ferrone S, Reisfeld R A (1981) Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera. J Immunol 126: 62
Garrigues H J, Tilgen W, Hellström I, Franke W, Hellström K E (1982) Detection of a human melanoma-associated antigen p97, in histological sections of primary human melanomas. Int J Cancer 29: 511
Ghose T, Blair A H (1978) Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. J Natl Cancer Inst 61: 657
Gilliland D G, Steplewski Z, Collier R J, Mitchell K F, Chang T H, Koprowski H (1980) Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. Proc Natl Acad Sci USA 77: 4539
Gold P, Freedman S O (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467
Goldenberg D M, DeLand F, Kim E, Bennett S, Primus F J, Van Nagell J R, Estes N, DeSimone P, Rayburn P (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298: 1384
Greaves M F (1979) Clinical value of leukaemia cell markers. In: Boelsma E, Rumke P (eds) Tumor markers. Impact and prospects. Elsevier/North-Holland Biomedical Press, Amsterdam, p 229
Greaves M F (1981) Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 41: 4752
Hakomori S I (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 733: 764
Halliday W J, Maluish A E, Little J H, Davis N C (1975) Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma. Int J Cancer 16: 645
Hamblin T J, Abdul-Abad A K, Gordon J, Stevenson F K, Stevenson G T (1980) Preliminary experience in treating lymphocytic leukemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer 42: 495
Hatzubai A, Maloney G G, Levy R (1981) The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. J Immunol 126: 2397
Hellström I, Brown J P, Hellström K E (1981) Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in clomplement-dependent cytotoxicity. J Immunol 127: 157
Hellström I, Brown J P, Klitzman J M, Hellström K E (1978) A highly sensitive and reproducible microcytotoxicity assay for demonstrating cytotoxic antibodies to cell surface antigens. J Immunol Methods 22: 369
Hellström I, Hellström K E, Shepard T H (1970) Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium. Int J Cancer 6: 346
Hellström I, Hellström K E, Pierce G E, Yang J P S (1968) Cellular and humoral immunity to different types of human neoplasms. Nature 220: 1352
Hellström I, Hellström K E, Sjögren H O, Warner G A (1981) Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer 7: 1
Hellström I, Hellström K E, Yeh M-Y (1981) Lymphocyte-dependent antibodies to antigen 3.1, a cell surface antigen expressed by a subgroup of human melanomas. Int J Cancer 27: 281
Hellström I, Rollins N, Settle S, Chapman P, Chapman W H, Hellström K E (1982) Monoclonal antibodies to two mouse bladder carcinoma antigens. Int J Cancer 29: 175
Hellström K E, Brown J P (1979) Tumor antigens. In: Sela M (ed) The antigens. Academic Press, New York, p 1
Hellström K E, Brown J P, Hellström I (1980) Monoclonal antibodies to tumor antigens. Contemp Top Immunobiol 11: 117
Herberman R B (1974) Cell-mediated immunity to tumor cells. Adv Cancer Res 19: 207
Herlyn M, Clark W H Jr, Mastangelo MJ, Guerry D IV, Elder D E, LaRosse D, Hamilton R, Bondi E, Tuthill R, Steplewski Z (1980) Specific immunoreactivity of monoclonal antimelanoma antibodies. Cancer Res 40: 3602
Herlyn D, Herlyn M, Steplewski Z, Koprowski H (1979) Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and coloractal carcinoma. Eur J Immunol 9: 657
Herlyn M, Steplewski Z, Herlyn D, Koprowski Z (1979) Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76: 1438
Herlyn D, Steplewski Z, Herlyn M, Koprowski H (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40: 717
Hollinshead A C, Herberman R B, Jaffurs W J, Alpert L K, Minton J P, Harris J E (1974) Soluble membrane antigens of human malignant melanoma cells. Cancer 34: 1235
Hosoi S, Nakamura T, Higashi S, Yamamuro T, Toyama S, Shinomiya K, Mikawa H (1982) Detection of human osteosarcoma-associated antigen(s) by monoclonal antibodies. Cancer Res 42: 654
Hurwitz E, Levy R, Maron R, Wilchek M, Arnon R, Sela M (1975) The covalent binding of daunomycin and adriamycin to antibodies with retention of both drug and antibody activities. Cancer Res 34: 1175
Imai K, Wilson B S, Kay N E, Ferrone S (1981) Monoclonal antibodies to human melanoma cells: comparisons of serological results of several laboratories and molecular profile of melanoma-associated antigens. In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol 3. Elsevier/North-Holland Biomedical Press, Amsterdam, p 183
Iwaki Y, Kasai M, Terasaki P I, Bernoco D, Park M S, Cicciarelli J, Heintz R, Saxton R E, Burk M W, Morton D L (1982) Monoclonal antibody against A1 Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma. Cancer Res 42: 409
Jansen F K, Blythman H E, Carriere D, Casellas P, Gros O, Gros P, Paolucci F, Pau B, Poncelet P, Richer G, Vidal H, Voisin G A (1981) Assembly and activity of conjugates between monoclonal antibodies and the toxic subunit of ricin (immunotoxins). In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol 3. Elsevier/North-Holland Biomedical Press, Amsterdam, p 229
Kaplan H S (1982) Closing remarks. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, Mew York, p 113
Kasai M, Saxton R E, Holmes E C, Burk M W, Morton D L (1981) Membrane antigens detected on human lung carcinoma cells by hybridoma monoclonal antibody. J Surg Res 30: 403
Kennel S J, Foote L J, Lankford P K (1981) Analysis of surface proteins of mouse lung carcinomas using monoclonal antibodies. Cancer Res 41: 3465
Kennett R H, Gilbert F (1979) Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain. Science 203: 1120
Kersey J H, LeBien T W, Abramson C S, Newman R, Sutherland D R, Greaves M (1981) p 24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med 153: 726
Kirch M E, Lee T, Hämmerling U (1981) Treatment of transplanted murine leukemias with monoclonal antibody; a model for passive immunotherapy. In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol. 3. Elsevier/North-Holland Biomedical Press, Amsterdam, p 221
Klein E, Holterman O A, Papermaster B, Milgrom H, Rosner D, Klein L, Walker M J, Zbar B (1973) Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives. Natl Cancer Inst Monogr 39: 229
Klein G, Clifford P, Klein E, Stjernswärd J (1966) Search for tumor-specific immune reactions in Burkitt's lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci USA 55: 1628
Klitzman J M, Brown J P, Hellström K E, Hellström I (1980) Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas. J Immunol 124: 2552
Köhler G, Milstein C (1975) Continuous culture of fused cells secreting antibodies of predefined specificity. Nature 256: 495
Koprowski H, Sears H, Herlyn M, Steplewski Z (1981) Specific antigen in serum of patients with colorectal carcinoma. Science 212: 53
Koprowski H, Steplewski Z, Herlyn D, Herlyn M (1978) Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 75: 3405
Koprowski H, Steplewski Z (1981) Human solid tumor antigens defined by monoclonal antibodies. In: Hämmerling G J, Hämmerling U, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Elsevier/North-Holland Biomedical Press, Amsterdam, p 161
Krolick K A, Isakson P C, Uhr J W, Vitetta E S (1979) BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. Immunol Rev 48: 81
Krolick K A, Villemez C, Isakson P, Uhr J W, Vitetta E S (1980) Selective killing of normal or neoplastic B-cells by antibodies coupled to the A chain of ricin. Proc Natl Acad Sci USA 77: 5419
Larson S M, Brown J P, Wright P W, Carrasquillo J A, Hellström I, Hellström K E (to be published) Imaging of melanoma with 131I-labelled monoclonal antibodies.
LeBien T W, McKenna R W, Abramson C S, Gajl-Peczalska K J, Nesbit M E, Coccia P F, Bloomfiled C D, Brunning R D, Kersey J H (1981) Use of monoclonal antibodies, morphology, cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma. Cancer Res 41: 4776
Lennox E S (1982) Monoclonal antibodies and tumor antigens. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 5
Lewis M G, Ikonopisov R L, Nairn R C, Phillips T M, Hamilton-Fairly G, Bodenham D C, Alexander P (1969) Tumor-specific antibodies in human malignant melanoma and their relationship to extent of disease. Br Med J 3: 547
Levy R, Dilley J (1978) Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic hybridization. Proc Natl Acad Sci USA 75: 2411
Levy R, Dilley J, Fox R I, Warnke R (1979) A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci USA 76: 6552
Loop S M, Nishiyama K, Hellström I, Woodbury R G, Brown J P, Hellström K E (1981) Two human tumor-associated antigens, p 155 and p 210, detected by monoclonal antibodies. Int J Cancer 27: 775
Mach J-P, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso J-L, Schreyer M, Girardet C, Accola R S, Carrel S (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscinitigraphy. Immunol Today 2: 239
Magnani J, Brockhaus M, Smith D F, Ginsburg V, Blaszczyk M, Mitchell K, Steplewski Z, Koprowski H (1981) A monosialoganglioside is a monoclonal antibody-defined antigen of colorectal carcinoma. Science 212: 55
Masuho Y, Hara T, Noguchi T (1979) Preparation of hybrid of fragment Fab′ of antibody and fragment of a diphtheria toxin and its cytotoxicity. Biochem Biophys Res Commun 90: 320
McCoy J L, Jerome L F, Dean J H, Perlin E, Oldham R K, Char D H, Cohen M H, Felix E L, Herberman R B (1975) Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J Natl Cancer Inst 55: 19
Melvin S L (1981) Immunological definition of leukemia cell surface phenotypes. Cancer Res 41: 4790–4793
Metzgar R S, Bergoc P M, Moreno M A, Seigler H F (1973) Melanoma-specific antibodies produced in monkey by immunization with human melanoma cell lines. J Natl Cancer Inst 50: 1065
Miller G G, Nadler P I, Asano Y, Hodes R J, Sachs D H (1981) Induction of idiotype-bearing nuclease-specific helper T cells by in vivo treatment of anti-idiotype. J Exp Med 154: 23
Miller R A, Maloney D G, Levy R (1981) In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood 58: 78
Miller R A, Maloney D G, Warnke R, Levy R (1981) Treatment of B-cell lymphoma with monoclonal antibody anti-idiotype antibody. N Engl J Med 306: 517
Miller R A, Maloney D, Warnke R, McDougall R, Wood G, Kawakami T, Dilley J, Goris M L, Levy R (1982) Considerations for treatment with hybridoma antibodies. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 133
Mitchell K, Fuhrer Z, Steplewski Z, Koprowski Z (1980) Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies. Proc Natl Acad Sci USA 77: 7267
Miyazaki H, Beppu M, Terao T, Osawa T (1980) Preparation of antibody (IgG)-ricin, A-chain conjugate and its biologic activity. Gann 71: 766
Morgan A. C., Galloway, D. R., Reisfeld, R. A. (1981) Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. Hybridoma 1: 27
Morton D L, Eilber F R, Holmes E C, Hunt J S, Ketcham A S, Silverstein M J, Sparks F C (1974) BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg 180:635
Morton D L, Malmgren R A, Holmes E C, Ketcham A S (1968) Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64: 233
National Institute of Allergy and Infectious Diseases NIAID (1977) Manual of Tissue Typing Techniques, DHEW no. (NIH) 76–545, GPO, Washington, D. C., p 22
Omary M B, Trowbridge I S, Minowada J M (1980) Human cell-surface glycoprotein with unusual properties. Nature 286: 888
Order S E, Klein J L, Ettinger D, Alderson P, Siegelman S, Leichner P (1980) Use of isotopic immunoglobulin in cancer therapy. Cancer Res 40: 3001
Pullen D J, Falleta J M, Crist W M, Vogler L B, Dowell B, Humphrey G B, Blackstock R, Van Eys J, Cooper M D, Metzgar R S, Meydrech E F (1981) Southwest oncology group experience with immunological phenotyping in acute lymphocytic leukemia of childhood. Cancer Res 41: 4802
Raso V, Ritz J, Basala M, Schlossman S T (1982) Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Cancer Res 42: 457
Reisfeld R A, Morgan A C Jr, Bumol T F (1982) Discussion: Production and characterization of a monoclonal antibody to human melanoma associated antigens. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 183
Ritz J, Pesando J M, Notis-McConarty J, Lazarus H, Schlossman S F (1980) A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature 283: 583
Ritz J, Pesando J M, Notis-McConarty J, Clavell L A, Sallan S E, Schlossman S F (1981) Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. Cancer Res 41: 4771
Rose T M (1981) Characterization of the surface proteins of cells transformed or abortively-infected with Simian Virus 40. Ph. D. Thesis Université de Geneve, Switzerland
Ruberto G, Imai K, Natali P G, Wilson B S, Ferrone S (1982) Discussion: Analysis of monoclonal antibodies to human melanoma cells. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 191
Sallen S E, Ritz J, Pesando J, Gelbar R, O'Brien C, Hitchcock S, Coral F, Schlossman S F (1980) Cell surface antigens; prognostic implications in childhood acute lymphoblastic leukemia. Blood 55: 395
Sandvig K, Olsnes S, Pihl A (1978) Chemical modification of the toxic lectins abrin and ricin. Eur J Biochem 84: 323
Schlom J, Wunderlich D, Teramoto Y A (1980) Generation of human monoclonal antibodies receive with human mammary carcinoma cells. Proc Natl Acad Sci USA 77: 6841
Shiku H, Takahashi T, Oettgen H F, Old L J (1976) Cell surface antigens of human malignant melanoma: II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med 144: 873
Sikora K, Wright R (1981) Human monoclonal antibodies to lung-cancer antigens. Br J Cancer 43: 696
Sondel P M, O'Brien C, Porter L, Schlossman S F, Chess L (1976) Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: Requirement for a proliferative trigger in vitro. J Immunol 117: 2197
Steplewski Z, Herlyn M, Herlyn D, Clark W H, Koprowski Z (1979) Reactivity of monoclonal antimelanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol 9: 94
Sternberger L A (1979) The unlabeled antibody peroxidase-antiperoxidase (PAP) method In: Immunocytochemistry. John Wiley Sons, New York, p 104
Stevenson G T, Elliott E V, Stevenson F K (1977) Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc 36: 2268
Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M (1981) Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci USA 78: 4515
Trowbridge I S, Domingo D L (to be published) Effects on growth of human tumor cells of anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates. Nature
Trowbridge I S, Omary M B (1981) Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78: 3039
Ueda R, Shiku H, Pfreundschuh M, Takahashi T, Li L T C, Whitmore W, Oettgen H F, Old L J (1979) Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med 150: 564
Uotila M, Envall E, Ruoslathi E (1980) Monoclonal antibodies to human alphafetoprotein. Mol Immunol 17: 791
Woodbury R G, Brown J P, Yeh M-Y, Hellström I, Hellström K E (1980) Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci USA 77: 2183
Woodbury R G, Brown J P, Loop S M, Hellström K E, Hellström I (1981) Analysis of normal and neoplastic human tissues for the tumor-associated protein p97. Int J Cancer 27: 145
Yeh M-Y, Hellström I, Brown J P, Warner G A, Hansen J A, Hellström K E (1979) Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci USA 76: 2927
Yeh M-Y, Hellström I, Hellström K E (1981) Clonal variation in expression of a human melanoma antigen defined by a monoclonal antibody. J Immunol 126: 1264
Yeh M-Y, Hellström I, Abe K, Hakomori S, Hellström K E (to be published) A cell surface antigen which is present in the ganglioside fraction and shared by human melanoma. Int J Cancer
Zamcheck N, Moore T L, Dhar P, Kupchik H (1972) Immunologic diagnosis and prognosis of human digestive-tract cancer: carcinoembryonic antigens. N Engl J Med 286: 83
Zighelboim J, Bick A, Durantez A (1977) “Recognition by human and rabbit sera of common antigens to leukemia blast cells, peripheral blood B-lymphocytes, and monocytes. Cancer Res 37: 3656
Zipf T F, Fox R L, Dilley J, Levy R (1981) Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies. Cancer Res 41: 4786
Author information
Authors and Affiliations
Additional information
This work was supported by grants CA 14135, 19148, 19149, CA 25558, CA 27841 from the National Institutes of Health, and IM 241A from the American Cancer Society. The authors wish to acknowledge collaboration with Drs. M.-Y. Yeh, R. G. Woodbury, S. M. Larson, and K. Nishiyama
Rights and permissions
About this article
Cite this article
Hellström, K.E., Hellström, I. & Brown, J.P. Human tumor-associated antigens identified by monoclonal antibodies. Springer Semin Immunopathol 5, 127–146 (1982). https://doi.org/10.1007/BF00199792
Issue Date:
DOI: https://doi.org/10.1007/BF00199792